Search Constraints
Search Results
Select an image to start the slideshow
A Statement
1 of 28
A Summary of the National Institutes of Health (USA) Guidelines for Recombinant DNA Research
2 of 28
Appendix C: Program of the International Conference on Recombinant DNA Molecules
3 of 28
Appendix D: Proposed Guidelines on Potential Biohazards Associated with Experiments Involving Genetically Altered Microorganisms
4 of 28
Appendix E: Preparation and Use of Recombinant Molecules Involving Animal Virus Genomes
5 of 28
Appendix E: Preparation and Use of Recombinant Molecules Involving Animal Virus Genomes
6 of 28
Appendix F: Cloned Eukaryotic DNA
7 of 28
Appendix H: Provisional Statement of the Conference Proceedings
8 of 28
Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
9 of 28
Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
10 of 28
Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
11 of 28
Appendix J: A Plausible Model for Monitoring Compliance with Containment Guidelines
12 of 28
Interview with Dr. Maxine F. Singer [on recombinant DNA research and NIH]
13 of 28
Letter from Maxine Singer to Francesco Blasi
14 of 28
Letter from Maxine Singer to Wallace P. Rowe
15 of 28
Letter from Maxine Singer to William J. Gartland
16 of 28
Letter from Roy Curtiss III to Donald S. Fredrickson
17 of 28
Letter from Roy Curtiss III to Maxine Singer
18 of 28
Letter from Stanley N. Cohen to Maxine Singer
19 of 28
Letter from Wallace P. Rowe to Maxine Singer
20 of 28
Memorandum from Allen Silverstone to the Advisory Committee on the Guidelines for Recombinant DNA
21 of 28
Memorandum from Maxine Singer to Donald S. Fredrickson
22 of 28
Memorandum from Maxine Singer to Paul Berg, David Baltimore, Sydney Brenner, and Richard O. Roblin on the latest draft of the Asilomar Reports
23 of 28
Memorandum from Paul Berg to the Organizing Committee for the Asilomar Conference on Recombinant DNA Molecules
24 of 28
Open Letter to the Asilomar Conference on Hazards of Recombinant DNA
25 of 28
Ordinance for the Use of Recombinant Molecule Technology in the City of Cambridge
26 of 28
Report of the Organizing Committee for the Asilomar Conference on Recombinant DNA Molecules
27 of 28
Testimony of Maxine Singer before the California State Legislature
28 of 28